Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Project Grant - PA: Antimicrobial Resistance (Bridge Grant)

McMaster University

$100,000.00

The Comprehensive Antibiotic Resistance Database: From Genes to Interpretation

EF 2024-25

Résumé
Antimicrobial resistance (AMR) is among the most pressing public health crises of the 21st Century as bacteria are evolving drug resistance faster than we can discover new drugs. Once treatable infectious diseases now include nearly untreatable strains. In addition, many of the 'miracles' of modern medicine, such as chemotherapy or routine surgery, are under threat due to a degraded ability to control secondary infection. Discovery of new antimicrobials is furthermore at an all-time low, making stewardship of our current antimicrobial arsenal critical. Yet, we have recently seen emergence of very serious threats to our last two 'drugs of last resort' - carbapenem effectiveness has been undermined by emergence of the resistance gene NDM-1 in 2006 and colistin effectiveness by emergence of the resistance gene MCR-1, first reported in November 2015. As such, while there is an urgent need to re-boot the drug discovery process for antimicrobials, we have an increasing need for better data for clinical practice, antimicrobial stewardship, and public health policy. In both a Canadian and global perspective, we need to know which resistance genes are prevalent, which genes are moving around, and which pose a threat. This Project Scheme proposal is focused on the accurate detection of resistome (the complement of resistance genes and mutations found in drug resistant infections) and their association with mobile genetic elements that allow them to rapidly jump from one pathogen to another, thus leading to extensively drug-resistant superbugs. Building upon our made-in-Canada Comprehensive Antibiotic Resistance Database, we propose development and application of advanced data science techniques, resistance gene detection models, and artificial intelligence for prediction of antibiotic resistance and the transmission of resistance genes regionally, nationally, and internationally.
Programme
Project Grant - PA: Antimicrobial Resistance (Bridge Grant)
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
514113
Name
Mcarthur Andrew G
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Microbiology & Infectious Diseases
Projecttitle
The Comprehensive Antibiotic Resistance Database: From Genes to Interpretation
Programtype2
Operating Grants
Orgnameinp2
McMaster University
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Project Grant - PA: Antimicrobial Resistance (Bridge Grant)
Keyworddelim
Antimicrobial Resistance; Biocuration; Bioinformatics; Biological Databases; Comprehensive Antibiotic Resistance Database; Genome Annotation; Genomic Epidemiology; Predictive Analysis; Resistome; Surveillance
Abstract
Antimicrobial resistance (AMR) is among the most pressing public health crises of the 21st Century as bacteria are evolving drug resistance faster than we can discover new drugs. Once treatable infectious diseases now include nearly untreatable strains. In addition, many of the 'miracles' of modern medicine, such as chemotherapy or routine surgery, are under threat due to a degraded ability to control secondary infection. Discovery of new antimicrobials is furthermore at an all-time low, making stewardship of our current antimicrobial arsenal critical. Yet, we have recently seen emergence of very serious threats to our last two 'drugs of last resort' - carbapenem effectiveness has been undermined by emergence of the resistance gene NDM-1 in 2006 and colistin effectiveness by emergence of the resistance gene MCR-1, first reported in November 2015. As such, while there is an urgent need to re-boot the drug discovery process for antimicrobials, we have an increasing need for better data for clinical practice, antimicrobial stewardship, and public health policy. In both a Canadian and global perspective, we need to know which resistance genes are prevalent, which genes are moving around, and which pose a threat. This Project Scheme proposal is focused on the accurate detection of resistome (the complement of resistance genes and mutations found in drug resistant infections) and their association with mobile genetic elements that allow them to rapidly jump from one pathogen to another, thus leading to extensively drug-resistant superbugs. Building upon our made-in-Canada Comprehensive Antibiotic Resistance Database, we propose development and application of advanced data science techniques, resistance gene detection models, and artificial intelligence for prediction of antibiotic resistance and the transmission of resistance genes regionally, nationally, and internationally.
Competitiondate
202409
Approvedterm2
1 yr 0 mth
Pinamesdelim
Mcarthur, Andrew G; Van Domselaar, Gary H
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~